APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy GMP Manufacturing Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell Therapy GMP Manufacturing Platform Market Analysis and Forecast 2026-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchCell Therapy GMP Manufacturing Platform Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy GMP Manufacturing Platform Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cell Therapy GMP Manufacturing Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy GMP Manufacturing Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy GMP Manufacturing Platform Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cell Therapy GMP Manufacturing Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell Therapy GMP Manufacturing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell Therapy GMP Manufacturing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell Therapy GMP Manufacturing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell Therapy GMP Manufacturing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell Therapy GMP Manufacturing Platform include Cellares, Miltenyi Biotec, Cytiva, Lonza, Adva Biotechnology, BioNTech, 3M, Ori Biotech and Limula, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell Therapy GMP Manufacturing Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell Therapy GMP Manufacturing Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Therapy GMP Manufacturing Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Therapy GMP Manufacturing Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Therapy GMP Manufacturing Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Therapy GMP Manufacturing Platform revenue, projected growth trends, production technology, application and end-user industry.

Cell Therapy GMP Manufacturing Platform Segment by Company

Cellares

Miltenyi Biotec

Cytiva

Lonza

Adva Biotechnology

BioNTech

3M

Ori Biotech

Limula

Resilience

Cellistic

Catalent

Criver

ElevateBio

Ultragenyx

Cell Therapy GMP Manufacturing Platform Segment by Type

Autologous Cell Therapy GMP Manufacturing Platform

Allogeneic Cell Therapy GMP Manufacturing Platform

Cell Therapy GMP Manufacturing Platform Segment by Application

Clinical Research

Commercial Production

Cell Therapy GMP Manufacturing Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy GMP Manufacturing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy GMP Manufacturing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy GMP Manufacturing Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell Therapy GMP Manufacturing Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell Therapy GMP Manufacturing Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy GMP Manufacturing Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy GMP Manufacturing Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Autologous Cell Therapy GMP Manufacturing Platform Major Player Table 3. Allogeneic Cell Therapy GMP Manufacturing Platform Major Player Table 4. Global Cell Therapy GMP Manufacturing Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Research Major Player Table 6. Commercial Production Major Player Table 7. Cell Therapy GMP Manufacturing Platform Industry Trends Table 8. Cell Therapy GMP Manufacturing Platform Industry Drivers Table 9. Cell Therapy GMP Manufacturing Platform Industry Opportunities and Challenges Table 10. Cell Therapy GMP Manufacturing Platform Industry Restraints Table 11. Global Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Cell Therapy GMP Manufacturing Platform Market Share by Region (2021-2026) Table 14. Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Cell Therapy GMP Manufacturing Platform Market Share by Region (2027-2032) Table 16. Global Cell Therapy GMP Manufacturing Platform Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Players (2021-2026) Table 18. Global Cell Therapy GMP Manufacturing Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cell Therapy GMP Manufacturing Platform Key Players Headquarters & Area Served Table 20. Global Cell Therapy GMP Manufacturing Platform Players, Product Type & Application Table 21. Global Cell Therapy GMP Manufacturing Platform Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Cell Therapy GMP Manufacturing Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Cell Therapy GMP Manufacturing Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Type (2021-2026) Table 28. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Type (2027-2032) Table 29. Global Cell Therapy GMP Manufacturing Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Application (2021-2026) Table 33. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Application (2027-2032) Table 34. Cellares Company Information Table 35. Cellares Business Overview Table 36. Cellares Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio Table 38. Cellares Recent Development Table 39. Miltenyi Biotec Company Information Table 40. Miltenyi Biotec Business Overview Table 41. Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio Table 43. Miltenyi Biotec Recent Development Table 44. Cytiva Company Information Table 45. Cytiva Business Overview Table 46. Cytiva Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio Table 48. Cytiva Recent Development Table 49. Lonza Company Information Table 50. Lonza Business Overview Table 51. Lonza Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio Table 53. Lonza Recent Development Table 54. Adva Biotechnology Company Information Table 55. Adva Biotechnology Business Overview Table 56. Adva Biotechnology Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio Table 58. Adva Biotechnology Recent Development Table 59. BioNTech Company Information Table 60. BioNTech Business Overview Table 61. BioNTech Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio Table 63. BioNTech Recent Development Table 64. 3M Company Information Table 65. 3M Business Overview Table 66. 3M Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. 3M Cell Therapy GMP Manufacturing Platform Product Portfolio Table 68. 3M Recent Development Table 69. Ori Biotech Company Information Table 70. Ori Biotech Business Overview Table 71. Ori Biotech Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio Table 73. Ori Biotech Recent Development Table 74. Limula Company Information Table 75. Limula Business Overview Table 76. Limula Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Limula Cell Therapy GMP Manufacturing Platform Product Portfolio Table 78. Limula Recent Development Table 79. Resilience Company Information Table 80. Resilience Business Overview Table 81. Resilience Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio Table 83. Resilience Recent Development Table 84. Cellistic Company Information Table 85. Cellistic Business Overview Table 86. Cellistic Cell Therapy GMP Manufacturing Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio Table 88. Cellistic Recent Development Table 89. Catalent Company Information Table 90. Catalent Business Overview Table 91. Catalent Cell Therapy GMP Manufacturing Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio Table 93. Catalent Recent Development Table 94. Criver Company Information Table 95. Criver Business Overview Table 96. Criver Cell Therapy GMP Manufacturing Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Criver Cell Therapy GMP Manufacturing Platform Product Portfolio Table 98. Criver Recent Development Table 99. ElevateBio Company Information Table 100. ElevateBio Business Overview Table 101. ElevateBio Cell Therapy GMP Manufacturing Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio Table 103. ElevateBio Recent Development Table 104. Ultragenyx Company Information Table 105. Ultragenyx Business Overview Table 106. Ultragenyx Cell Therapy GMP Manufacturing Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio Table 108. Ultragenyx Recent Development Table 109. North America Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Cell Therapy GMP Manufacturing Platform Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Cell Therapy GMP Manufacturing Platform Revenue by Country (US$ Million) & (2027-2032) Table 123. China Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026) & (US$ Million) Table 124. China Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032) & (US$ Million) Table 125. China Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026) & (US$ Million) Table 126. China Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Cell Therapy GMP Manufacturing Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Cell Therapy GMP Manufacturing Platform Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Cell Therapy GMP Manufacturing Platform Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Cell Therapy GMP Manufacturing Platform Image Figure 2. Global Cell Therapy GMP Manufacturing Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Therapy GMP Manufacturing Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Autologous Cell Therapy GMP Manufacturing Platform Image Figure 5. Allogeneic Cell Therapy GMP Manufacturing Platform Image Figure 6. Global Cell Therapy GMP Manufacturing Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cell Therapy GMP Manufacturing Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Research Image Figure 9. Commercial Production Image Figure 10. Global Cell Therapy GMP Manufacturing Platform Market Size (US$ Million) & (2021-2032) Figure 11. Global Cell Therapy GMP Manufacturing Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cell Therapy GMP Manufacturing Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Cell Therapy GMP Manufacturing Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Cell Therapy GMP Manufacturing Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Type (2021-2032) Figure 18. Global Cell Therapy GMP Manufacturing Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Application (2021-2032) Figure 21. North America Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032) Figure 23. North America Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032) Figure 24. North America Cell Therapy GMP Manufacturing Platform Revenue Share by Country (2021-2032) Figure 25. United States Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032) Figure 30. Europe Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032) Figure 31. Europe Cell Therapy GMP Manufacturing Platform Revenue Share by Country (2021-2032) Figure 32. Germany Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032) Figure 42. China Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032) Figure 43. Asia Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032) Figure 45. Asia Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032) Figure 46. Asia Cell Therapy GMP Manufacturing Platform Revenue Share by Region (2021-2032) Figure 47. Japan Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032) Figure 55. SAMEA Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032) Figure 56. SAMEA Cell Therapy GMP Manufacturing Platform Revenue Share by Country (2021-2032) Figure 57. Brazil Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Cell Therapy GMP Manufacturing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Cell Therapy GMP Manufacturing Platform
  • Allogeneic Cell Therapy GMP Manufacturing Platform
Applications
  • Clinical Research
  • Commercial Production
Companies covered
  • Cellares
  • Miltenyi Biotec
  • Cytiva
  • Lonza
  • Adva Biotechnology
  • BioNTech
  • 3M
  • Ori Biotech
  • Limula
  • Resilience
  • Cellistic
  • Catalent
  • Criver
  • ElevateBio
  • Ultragenyx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell Therapy GMP Manufacturing Platform Market by Type
  3. 1.2.1 Global Cell Therapy GMP Manufacturing Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Autologous Cell Therapy GMP Manufacturing Platform
  5. 1.2.3 Allogeneic Cell Therapy GMP Manufacturing Platform
  6. 1.3 Cell Therapy GMP Manufacturing Platform Market by Application
  7. 1.3.1 Global Cell Therapy GMP Manufacturing Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical Research
  9. 1.3.3 Commercial Production
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Cell Therapy GMP Manufacturing Platform Market Dynamics
  1. 2.1 Cell Therapy GMP Manufacturing Platform Industry Trends
  2. 2.2 Cell Therapy GMP Manufacturing Platform Industry Drivers
  3. 2.3 Cell Therapy GMP Manufacturing Platform Industry Opportunities and Challenges
  4. 2.4 Cell Therapy GMP Manufacturing Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell Therapy GMP Manufacturing Platform Market Perspective (2021-2032)
  2. 3.2 Global Cell Therapy GMP Manufacturing Platform Growth Trends by Region
  3. 3.2.1 Global Cell Therapy GMP Manufacturing Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell Therapy GMP Manufacturing Platform Revenue by Players
  2. 4.1.1 Global Cell Therapy GMP Manufacturing Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell Therapy GMP Manufacturing Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell Therapy GMP Manufacturing Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell Therapy GMP Manufacturing Platform Key Players Headquarters & Area Served
  7. 4.4 Global Cell Therapy GMP Manufacturing Platform Players, Product Type & Application
  8. 4.5 Global Cell Therapy GMP Manufacturing Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell Therapy GMP Manufacturing Platform Market CR5 and HHI
  11. 4.6.3 2025 Cell Therapy GMP Manufacturing Platform Tier 1, Tier 2, and Tier 3
5 Cell Therapy GMP Manufacturing Platform Market Size by Type
  1. 5.1 Global Cell Therapy GMP Manufacturing Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2032)
  3. 5.3 Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Type (2021-2032)
6 Cell Therapy GMP Manufacturing Platform Market Size by Application
  1. 6.1 Global Cell Therapy GMP Manufacturing Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2032)
  3. 6.3 Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cellares
  2. 7.1.1 Cellares Company Information
  3. 7.1.2 Cellares Business Overview
  4. 7.1.3 Cellares Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio
  6. 7.1.5 Cellares Recent Developments
  7. 7.2 Miltenyi Biotec
  8. 7.2.1 Miltenyi Biotec Company Information
  9. 7.2.2 Miltenyi Biotec Business Overview
  10. 7.2.3 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio
  12. 7.2.5 Miltenyi Biotec Recent Developments
  13. 7.3 Cytiva
  14. 7.3.1 Cytiva Company Information
  15. 7.3.2 Cytiva Business Overview
  16. 7.3.3 Cytiva Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio
  18. 7.3.5 Cytiva Recent Developments
  19. 7.4 Lonza
  20. 7.4.1 Lonza Company Information
  21. 7.4.2 Lonza Business Overview
  22. 7.4.3 Lonza Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio
  24. 7.4.5 Lonza Recent Developments
  25. 7.5 Adva Biotechnology
  26. 7.5.1 Adva Biotechnology Company Information
  27. 7.5.2 Adva Biotechnology Business Overview
  28. 7.5.3 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio
  30. 7.5.5 Adva Biotechnology Recent Developments
  31. 7.6 BioNTech
  32. 7.6.1 BioNTech Company Information
  33. 7.6.2 BioNTech Business Overview
  34. 7.6.3 BioNTech Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio
  36. 7.6.5 BioNTech Recent Developments
  37. 7.7 3M
  38. 7.7.1 3M Company Information
  39. 7.7.2 3M Business Overview
  40. 7.7.3 3M Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 3M Cell Therapy GMP Manufacturing Platform Product Portfolio
  42. 7.7.5 3M Recent Developments
  43. 7.8 Ori Biotech
  44. 7.8.1 Ori Biotech Company Information
  45. 7.8.2 Ori Biotech Business Overview
  46. 7.8.3 Ori Biotech Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio
  48. 7.8.5 Ori Biotech Recent Developments
  49. 7.9 Limula
  50. 7.9.1 Limula Company Information
  51. 7.9.2 Limula Business Overview
  52. 7.9.3 Limula Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Limula Cell Therapy GMP Manufacturing Platform Product Portfolio
  54. 7.9.5 Limula Recent Developments
  55. 7.10 Resilience
  56. 7.10.1 Resilience Company Information
  57. 7.10.2 Resilience Business Overview
  58. 7.10.3 Resilience Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio
  60. 7.10.5 Resilience Recent Developments
  61. 7.11 Cellistic
  62. 7.11.1 Cellistic Company Information
  63. 7.11.2 Cellistic Business Overview
  64. 7.11.3 Cellistic Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio
  66. 7.11.5 Cellistic Recent Developments
  67. 7.12 Catalent
  68. 7.12.1 Catalent Company Information
  69. 7.12.2 Catalent Business Overview
  70. 7.12.3 Catalent Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio
  72. 7.12.5 Catalent Recent Developments
  73. 7.13 Criver
  74. 7.13.1 Criver Company Information
  75. 7.13.2 Criver Business Overview
  76. 7.13.3 Criver Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Criver Cell Therapy GMP Manufacturing Platform Product Portfolio
  78. 7.13.5 Criver Recent Developments
  79. 7.14 ElevateBio
  80. 7.14.1 ElevateBio Company Information
  81. 7.14.2 ElevateBio Business Overview
  82. 7.14.3 ElevateBio Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio
  84. 7.14.5 ElevateBio Recent Developments
  85. 7.15 Ultragenyx
  86. 7.15.1 Ultragenyx Company Information
  87. 7.15.2 Ultragenyx Business Overview
  88. 7.15.3 Ultragenyx Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio
  90. 7.15.5 Ultragenyx Recent Developments
8 North America
  1. 8.1 North America Cell Therapy GMP Manufacturing Platform Revenue (2021-2032)
  2. 8.2 North America Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032)
  5. 8.3 North America Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032)
  9. 8.5 North America Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell Therapy GMP Manufacturing Platform Revenue by Country
  11. 8.6.1 North America Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell Therapy GMP Manufacturing Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell Therapy GMP Manufacturing Platform Revenue (2021-2032)
  2. 9.2 Europe Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell Therapy GMP Manufacturing Platform Revenue by Country
  11. 9.6.1 Europe Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell Therapy GMP Manufacturing Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell Therapy GMP Manufacturing Platform Revenue (2021-2032)
  2. 10.2 China Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032)
  5. 10.3 China Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032)
  9. 10.5 China Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell Therapy GMP Manufacturing Platform Revenue (2021-2032)
  2. 11.2 Asia Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell Therapy GMP Manufacturing Platform Revenue by Country
  11. 11.6.1 Asia Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell Therapy GMP Manufacturing Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell Therapy GMP Manufacturing Platform Revenue (2021-2032)
  2. 12.2 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell Therapy GMP Manufacturing Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell Therapy GMP Manufacturing Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country
  11. 12.6.1 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell Therapy GMP Manufacturing Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst